The main novel finding of the present study, obtained by analyzing public glioma and neural tissue data, is the association of poorer patient outcome assessed by a reduction in OS in patients with high CSF3R/CD114 mRNA expression in different types of glioma tumors. This evidence concerns the gene CSF3R and central nervous system cancer.